Do chemokines play a role in HIV-1 heterosexual transmission? Susceptibility to HIV infection

Journal of Biological Regulators and Homeostatic Agents

Volumn 13, Issue 2, 1999, Pages 97-102

  D'Ubaldo, C ^a   Serraino, D ^a   Peroni, M ^a   Ippolito, G ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Chemokines; Heterosexual transmission; HIV; Host determinants; Resistance; Susceptibility

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; BASE PAIRING; CELL SURFACE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACROPHAGE; SEXUAL TRANSMISSION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0033303410     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Sexual transmission of HIV
2. First 500,000 AIDS cases - United States, 1995
3. Sexual transmission of HIV: Infectiousness and prevention
4. Genetic and immonological host factors associated with susceptibility to HIV-1 infection
5. Comparative investigation of Langherans' cells and potential receptors for HIV in oral, genito-urinary, and rectal epithelia
6. Identification of a major co-receptor for primary isolates of HIV-1
7. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CCCKR-5
8. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
9. Repertoire of chemokine receptor expression in the female genital tract. Implications for human immunodeficiency virus transmission
10. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
11. CD4-induced interaction of primary HIV-1 gp 120 glycoproteins with the chemokine receptor CCR-5
12. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
13. Expression and function of CCR5 and CXCR4 on human Langherans cells and macrophages: Implications for primary infection
14. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1
15. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure
16. Resistance to HIV-1 infection in Caucasan individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
17. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiple-exposed individuals to HIV-1 infection
18. Genetic restriction of HIV-1 infection in infection and progression to AIDS by a deletion allele of the CKR5 structural gene
19. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
20. The extent of genetic variation in the CCR5 gene
21. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status
22. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
23. CCR5 genotype and sexual transmission of HIV-1
24. HIV-1 infection in a man homozygous for CCR5d32
25. HIV infection in an individual homozygous for CCR5d32
26. Homozygous d32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
27. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the d32-CCR5 mutation
28. Non-ulcerative sexually transmitted diseases as a risk factors for HIV-1 transmission in women: Results from a cohort study
29. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV
30. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immonusuppression in female sex workers in Abidjan, Cote d'Ivoire
31. Treponema pallidum lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kB activation
32. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
33. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases
34. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes
35. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: A mechanism for enhanced HIV-1 transmission?
36. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1
37. HIV-specific T-helper activity in seronegative health-care workers exposed to contamined blood
38. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens
39. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
40. Cytotoxic T-lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1 infected mothers
41. HIV-1 specific immunity in persistently seronegative individuals at high risk for HIV infection
42. Nontransmission of HIV: A multifactorial phenomenon
43. Protective immunity against HIV infection: Has nature done the experiment for us?
44. Identification of RANTES, MIP-1 α, and MIP-1 β as the major HIV-suppressive factors produced by CD8+ T cells
45. CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1 α, and MIP-1 β, suppress HIV-1 replication in monocyte/macrophages
46. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T-cells from exposed uninfected individuals expressing the wild-type CCR5 allele
47. HIV-specific cytotoxic T-lymphocytes in person exposed through sexual contact with HIV-infected patients
48. CD8+ T-cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells
49. Analysis of CD8+ T-lymphocyte-mediated nonlytic suppression of autologous and heterologous primary human immunodeficiency virus type 1 isolates
50. Inhibition of HIV-1 infection by the β-chemokine MDC
51. Role of β-chemokines in suppressing HIV replication
52. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: A review of the literature examining associations with HLA
53. Resistance to HIV infection among persistently seronegative prostitute in Nairobi, Kenya
54. Quantitative specific IgG, IgA, IgM antibodies in human genital secretions
55. Mucosal immune responses in four distinct compartments of women infected with HIV-1: A comparison by site and correlation with clinical information
56. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex worker
57. Potent inhibition of HIV-i infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
58. HIV type 1 vaccine-induced cytotoxic T-cell responses in phase I clinical trials: Detection, characterization and quantification